Literature DB >> 15688074

Multicomponent therapeutics for networked systems.

Curtis T Keith1, Alexis A Borisy, Brent R Stockwell.   

Abstract

Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.

Mesh:

Year:  2005        PMID: 15688074     DOI: 10.1038/nrd1609

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  226 in total

Review 1.  Drug discovery enters a new era with multi-target intervention strategy.

Authors:  Xiao-ying Tian; Liang Liu
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

2.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 3.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 4.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

Review 5.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

6.  Mechanism-independent method for predicting response to multidrug combinations in bacteria.

Authors:  Kevin Wood; Satoshi Nishida; Eduardo D Sontag; Philippe Cluzel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

Review 7.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

8.  Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma.

Authors:  Kelly M Zullo; Yige Guo; Laurence Cooke; Xavier Jirau-Serrano; Michael Mangone; Luigi Scotto; Jennifer E Amengual; Yinghui Mao; Renu Nandakumar; Serge Cremers; Jimmy Duong; Daruka Mahadevan; Owen A O'Connor
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

Review 9.  Biological screening of natural products and drug innovation in China.

Authors:  Ming-Wei Wang; Xiaojiang Hao; Kaixian Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

10.  Drosophila Cancer Models Identify Functional Differences between Ret Fusions.

Authors:  Sarah Levinson; Ross L Cagan
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.